Zobrazeno 1 - 10
of 104
pro vyhledávání: '"MIOCARDIOPATIA HIPERTRÓFICA"'
Autor:
André Grazina, Isabel Cardoso, António Fiarresga, Sílvia Aguiar Rosa, Pedro Garcia Brás, Vera Ferreira, José Miguel Viegas, Bárbara Lacerda Teixeira, Rúben Ramos, Lídia de Sousa, Mário Martins Oliveira, Ana Galrinho, Duarte Cacela, Rui Cruz Ferreira
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 43, Iss 1, Pp 13-19 (2024)
Introduction and objectives: Patients with hypertrophic obstructive cardiomyopathy (HOCM) that remain symptomatic despite optimized medical therapy often undergo alcohol septal ablation (ASA). One of the most frequent complications is complete heart
Externí odkaz:
https://doaj.org/article/33628b4bac394637b979542f9070ebca
Autor:
Kamilla Leite Morbeck Teixeira, Edileide de Barros Correia, Cíntia Galhardo Tressino, Marcela Momesso Peçanha, Walter Antonio Melchior, Rodrigo Bellio de Mattos Barretto, Bruna Gomes de Medeiros, David Le Bihan
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 9, Pp 771-779 (2022)
Introduction and objectives: Hypertrophic cardiomyopathy (HCM) is accompanied by pathophysiological changes that predispose to the development of atrial fibrillation (AF). This arrhythmia impacts negatively on the morbidity, mortality and quality of
Externí odkaz:
https://doaj.org/article/39aea502757c40dfa1a79223dd8807d3
Autor:
Sílvia Aguiar Rosa, Miguel Mota Carmo, Luís Rocha Lopes, Eunice Oliveira, Boban Thomas, Luis Baquero, Rui Cruz Ferreira, António Fiarresga
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 9, Pp 761-767 (2022)
Introduction and objectives: Coronary microvascular dysfunction (CMD) is one of the most important pathophysiological features in hypertrophic cardiomyopathy (HCM). The index of microcirculatory resistance (IMR) is an invasive method to assess the co
Externí odkaz:
https://doaj.org/article/e72d4b17eed54305ad263c09d058aeaf
Autor:
Tiago Aguiar, Elisabete Martins
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 8, Pp 693-703 (2022)
Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac diseases, defined as a left ventricular wall thickness of ≥15 mm, in the absence of other causes of abnormal ventricular loading. A major hallmark of this disease is the
Externí odkaz:
https://doaj.org/article/76d8c9425878437fbf170b19a304bb0a
Autor:
Pedro Garcia Brás, Sílvia Aguiar Rosa, Boban Thomas, António Fiarresga, Isabel Cardoso, Ricardo Pereira, Gonçalo Branco, Inês Cruz, Luís Baquero, Rui Cruz Ferreira, Miguel Mota Carmo, Luís Rocha Lopes
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 7, Pp 559-568 (2022)
Background: Microvascular dysfunction is an often overlooked feature of hypertrophic cardiomyopathy (HCM). Our aim was to assess the association between microvascular dysfunction, wall thickness, tissue characteristics and myocardial deformation in H
Externí odkaz:
https://doaj.org/article/1d15ff6126cd473d9634c22b8b8299af
Autor:
Alexandra Toste
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 6, Pp 499-509 (2022)
Hypertrophic cardiomyopathy (HCM) is known as the most common genetic heart disease, characterized by otherwise unexplained left ventricular (LV) hypertrophy. In spite of major advances in whole genome sequence techniques, it is still not possible to
Externí odkaz:
https://doaj.org/article/61ad169c2c674762b2896e80d5c6da70
Autor:
Ana Raquel Barbosa, João Almeida, Cláudio Guerreiro, Pedro Teixeira, Ricardo Ladeiras Lopes, Nuno Dias Ferreira, Olga Sousa, Pedro Braga
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 39, Iss 11, Pp 615-621 (2020)
Introduction and Objectives: Late gadolinium enhancement (LGE) extent has emerged as a predictor of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM), however little is known about the arrhythmogenic relevance of its speci
Externí odkaz:
https://doaj.org/article/f364d0292c064d3b9f16a1456ff5f627
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 39, Iss 6, Pp 317-327 (2020)
Introduction and objectives: Hypertrophic cardiomyopathy (HCM) is a genetically and phenotypically heterogeneous disease; there is still a large proportion of patients with no identified disease-causing mutation. Although the majority of mutations ar
Externí odkaz:
https://doaj.org/article/5c4f4bdf0c9f4acfaab987594dbc02b7
Autor:
Martín Negreira-Caamaño, Jesús Piqueras-Flores, Inmaculada Vivo-Ortega, María Arántzazu-González-Marín, Manuel Muñoz-García, Alberto Jiménez-Lozano
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 40, Iss 3, Pp 221-223 (2021)
Introduction and objectives: According to current international guidelines, hypertrophic cardiomyopathy (HCM) patients should be managed in specialized units. However, there is lack of data on the impact of the creation of these units in the manageme
Externí odkaz:
https://doaj.org/article/63957aa3e1054a50a87c3eebb6db2cc5
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 40, Iss 10, Pp 801.e1-801.e6 (2021)
Hypertrophic cardiomyopathy is one of the main causes of sudden cardiac death in young athletes. Differentiating between this pathological condition and ‘athlete's heart’ can be quite challenging, warranting a thorough clinical and imaging assess
Externí odkaz:
https://doaj.org/article/89dc232804894b618df5bcf9219aa62b